Novel combination therapy for the eradication of Helicobacter pylori infection in a mouse model

References

• Eslick GD. Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic, and experimental evidence. World J Gastroenterol 2006;12:2991–9.
   PubMedGoogle Scholar
• Pilotto A, Leandro G, Franceschi M, Bierti L, Di Battista R, Notarbartolo A, Rapid improvement of symptomatology with pantoprazole, amoxycillin and metronidazole in Helicobacter pylori-positive duodenal ulcer patients. Hepatogastroenterology 1999;46:245–51.
   PubMedGoogle Scholar
• de Boer WA. Topics in Helicobacter pylori infection: focus on a ‘search-and-treat’ strategy for ulcer disease. Scand J Gastroenterol Suppl 2000;232:4–9.
   Google Scholar
• Marnila P, Rokka S, Rehnberg-Laiho L, Karkkainen P, Kosunen TU, Rautelin H, Prevention and suppression of Helicobacter felis infection in mice using colostral preparation with specific antibodies. Helicobacter 2003;8:192–201.
   PubMedGoogle Scholar
• Casswall TH, Nilsson HO, Bjorck L, Sjostedt S, Xu L, Nord CK, Bovine anti-Helicobacter pylori antibodies for oral immunotherapy. Scand J Gastroenterol 2002;37:1380–5.
   PubMed Web of Science ®Google Scholar
• Casswall TH, Sarker SA, Albert MJ, Fuchs GJ, Bergstrom M, Bjorck L, Treatment of Helicobacter pylori infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colostrum. Aliment Pharmacol Ther 1998;12:563–8.
   Google Scholar
• Opekun AR, El-Zaimaity HM, Osato MS, Gilger MA, Malaty HM, Terry M, Novel therapies for Helicobacter pylori infection. Aliment Pharmacol Ther 1999;13:35–42.
   PubMed Web of Science ®Google Scholar
• Huynh HQ, Couper RT, Tran CD, Moore L, Kelso R, Butler RN. N-acetylcysteine, a novel treatment for Helicobacter pylori infection. Dig Dis Sci 2004;49:1853–61.
   PubMed Web of Science ®Google Scholar
• Ziment I. Acetylcysteine: a drug with an interesting past and a fascinating future. Respiration 1986;50(Suppl 1):26–30.
   PubMedGoogle Scholar
• Matthews GM, Butler RN. Cellular mucosal defense during Helicobacter pylori infection: a review of the role of glutathione and the oxidative pentose pathway. Helicobacter 2005;10:298–306.
   PubMedGoogle Scholar
• Nishiwaki H, Kato S, Sugamoto S, Umeda M, Morita H, Yoneta T, Ulcerogenic and healing impairing actions of monochloramine in rat stomachs: effects of zinc L-carnosine, polaprezinc. J Physiol Pharmacol 1999;50:183–95.
   PubMedGoogle Scholar
• Tran CD, Campbell MA, Kolev Y, Chamberlain S, Huynh HQ, Butler RN. Short-term zinc supplementation attenuates Helicobacter felis-induced gastritis in the mouse. J Infect 2005;50:417–24.
   PubMedGoogle Scholar
• Kashimura H, Suzuki K, Hassan M, Ikezawa K, Sawahata T, Watanabe T, Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection. Aliment Pharmacol Ther 1999;13:483–7.
   PubMed Web of Science ®Google Scholar
• Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997;112:1386–97.
   PubMed Web of Science ®Google Scholar
• Lee A, Fox JG, Otto G, Murphy J. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology 1990;99:1315–23.
   PubMed Web of Science ®Google Scholar
• Pacyna J, Siwek K, Terry SJ, Roberton ES, Johnson RB, Davidson GP. Survival of rotavirus antibody activity derived from bovine colostrum after passage through the human gastrointestinal tract. Pediatr Gastroenterol Nutr 2001;32:162–7.
   PubMed Web of Science ®Google Scholar
• Symonds E, Butler R, Omari T. Non-invasive breath tests can detect alterations in gastric emptying in the mouse. Eur J Clin Invest 2002;32:341–4.
   PubMedGoogle Scholar
• Stolte M, Meining A. The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can J Gastroenterol 2001;15:591–8.
   PubMed Web of Science ®Google Scholar
• Korhonen H, Syväoja EL, Ahola-Luttila H, Sivelä S, Kopola S, Husu J, Bactericidal effect of bovine normal and immune serum, colostrum and milk against Helicobacter pylori. J Appl Bacteriol 1995;78:655–62.
   PubMedGoogle Scholar
• Kashimura H, Suzuki K, Hassan M, Ikezawa K, Sawahata T, Watanabe T, Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection. Aliment Pharmacol Ther 1999;13:483–7.
   PubMed Web of Science ®Google Scholar
• Troskot B, Simicevic VN, Dodig M, Rotkvic I, Ivankovic D, Duvnjak M. The protective effect of zinc sulphate pretreatment against duodenal ulcers in the rat. Biometals 1997;10:325–9.
   PubMedGoogle Scholar
• Escolar G, Bulbena O. Zinc compounds, a new treatment in peptic ulcer. Drugs Exp Clin Res 1989;15:83–9.
   PubMedGoogle Scholar
• Ravelli AM, Tobanelli P, Volpi S, Ugazio AG. Vomiting and gastric motility in infants with cow's milk allergy. J Pediatr Gastroenterol Nutr 2001;32:59–64.
   PubMedGoogle Scholar
• Parkman HP, Urbain JL, Knight LC, Brown KL, Trate DM, Miller MA, Effect of gastric acid suppressants on human gastric motility. Gut 1998;42:243–50.
   PubMed Web of Science ®Google Scholar
• Chiloiro M, Russo F, Riezzo G, Leoci C, Clemente C, Catrina M, Effect of Helicobacter pylori infection on gastric emptying and gastrointestinal hormones in dyspeptic and healthy subjects. Dig Dis Sci 2001;46:46–53.
   PubMedGoogle Scholar
• Duval-Araujo I, De Magal-Aes Queiroz D, Magnago A, Simal C, Marino VS, Carvalho S, Increased gastric emptying induced by Helicobacter heilmannii type 1 infection in rats. J Med Microbiol 2000;49:627–34.
   PubMedGoogle Scholar
• Domínguez-Munõz J, Malfertheiner P. Effect of Helicobacter pylori infection on gastrointestinal motility, pancreatic secretion and hormone release in asymptomatic humans. Scand J Gastroenterol 2001;36:1141–7.
   PubMed Web of Science ®Google Scholar
• Murakami K, Fujioka T, Shiota K, Ito A, Fujiyama K, Kodama R, Influence of Helicobacter pylori infection and the effects of its eradication on gastric emptying in non-ulcerative dyspepsia. Eur J Gastroenterol Hepatol 1995;7:S93–7.
   Google Scholar
• Debas H, Farooq O, Grossman M. Inhibition of gastric emptying is a physiological action of cholecystokinin. Gastroenterology 1975;68:1211–17.
   PubMed Web of Science ®Google Scholar
• Konturek J, Stoll R, Menzel J, Konturek M, Konturek S, Domschke W. Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on gastric motility in duodenal ulcer patients. Scand J Gastroenterol 2001;36:241–6.
   PubMedGoogle Scholar
• Moran T, Wirth J, Schwartz G, McHugh P. Interactions between gastric volume and duodenal nutrients in the control of liquid gastric emptying. Am J Physiol 1999;76:R997–1002.
   Google Scholar
• van der Schaar PJ, Straathof JW, Veenendaal RA, Lamers CB, Masclee AA. Does Helicobacter pylori gastritis affect motor function of proximal stomach in dyspeptic patients? Dig Dis Sci 2001;46:1833–8.
   PubMedGoogle Scholar
• Stanghellini V, Barbara G, de Giorgio R, Tosetti C, Cogliandro R, Cogliandro L, Helicobacter pylori, mucosal inflammation and symptom perception – new insights into an old hypothesis. Aliment Pharmacol Ther 2001;15(Suppl 1):28–32.
   PubMedGoogle Scholar